Liminatus Pharma LIMN
NASDAQ LIMN
$3.73 -0.18 (-4.60%)
At close: Sep 30, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Market Capitalization (2025 - 2026)

Updated

Liminatus Pharma's Market Capitalization was $6.16 million in Q2 2026, down 98.0% from $301.77 million a year earlier and down 0.6% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Market Capitalization (2025 - 2026) Analysis & Trends

For FY2025, Market Capitalization at Liminatus Pharma came in at $16.51 million.

  • Per Business Quant data, LIMN's Market Capitalization in the three quarters before Q2 2026 was $6.19 million (Q1 2026), $16.51 million (Q4 2025) and $45.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Liminatus Pharma 4.38 Mn 4.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.16 Mn
Mar 31, 2026 6.19 Mn
Dec 31, 2025 16.51 Mn
Sep 30, 2025 45.20 Mn
Jun 30, 2025 301.77 Mn
API Access

Liminatus Pharma Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=LIMN&period=max&api_key=YOUR_API_KEY